Thirdly, the heightened transcript levels of these chosen proteins were associated with diminished patient survival rates (with statistical significance at p < 0.05 in a 50% low vs. 50% high comparison) in cases of PDAC and other cancer types, with the exception of LZM and CD74. Here, LYZ is linked to cancer.